EUVIMEDEUVIMED entdecken
Open Access

Altered B cell metabolic pathways characterize type 1 diabetes progression

Holly Conway, Jessica Bernard, Rachel Ramos, Sama Zahran, Dianna L Perez iD, Mugtaba Swar-Eldahab, Jon Piganelli, Carmella Evans-Molina iD, Jamie L Felton iD

The Journal of Immunology · 2026

DOI: 10.1093/jimmun/vkaf330 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2026. Verfasst von Holly Conway und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Pediatric Endocrinology, Indiana University School of Medicine, Indianapolis, IN, United States. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, B-Lymphocytes, Regulatory, Metabolic Networks and Pathways, B-Lymphocytes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCATS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 1 diabetes (T1D) results from immune-mediated destruction of pancreatic beta cells. B cells serve as critical antigen-presenting cells whose autoreactive specificities drive disease progression. Conversely, IL-10 producing regulatory B cells (Bregs) exert immunosuppressive functions and have been shown to protect against autoimmunity in mouse models of rheumatoid arthritis and multiple sclerosis, where microenvironmental cues promote their differentiation. In particular, signaling through hypoxia-inducible factor 1α (HIF-1α) induces glycolytic flux that supports Breg expansion. Defects in Breg development and function have been identified in both human T1D and the non-obese diabetic (NOD) mouse, but whether these impairments reflect intrinsic B-cell abnormalities or microenvironmental changes associated with hyperglycemia and inflammation remains unclear. Moreover, the mechanisms by which B cells suppress pathogenic T-cell responses likely vary across disease states. Here, we examine how B cell differentiation, metabolism, and HIF-1α signaling interact to shape immune regulation in autoimmune diabetes. We show that B cells undergo dynamic metabolic remodeling during disease progression. B cells from NOD mice are characterized by exaggerated glucose uptake and elevated IL-10 expression compared with non-autoimmune B6 B cells, despite reduced HIF-1α levels and attenuated induction of HIF-dependent glycolytic genes. These findings indicate that HIF-1α plays a diminished role in controlling IL-10 production in NOD B cells and that IL-10 alone is insufficient to maintain immune tolerance. Together, our results highlight how genetic and microenvironmental factors reprogram B cell metabolism and underscore the need to explore IL-10 independent pathways and B-cell extrinsic mechanisms when developing immunomodulatory therapies for T1D.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1B-Lymphocytes, RegulatoryMetabolic Networks and PathwaysB-LymphocytesAnimalsMiceHypoxia-Inducible Factor 1, alpha SubunitMice, Inbred NODDisease ProgressionInterleukin-10Signal TransductionCell DifferentiationHumansGlycolysisFemale

Stichwörter der Autor:innen

B cellhypoxiaimmunometabolismtype 1 diabetes

Substanzen

Hypoxia-Inducible Factor 1, alpha SubunitHif1a protein, mouseInterleukin-10

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Pediatric Endocrinology, Indiana University School of Medicine, Indianapolis, IN, United States.
  • Department of Pediatrics and the Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN, United States.
  • Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, United States.
  • Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN, United States.

ORCID-Profile: Dianna L Perez, Carmella Evans-Molina, Jamie L Felton

Förderung

  • NIDDK NIH HHS
  • NCATS NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Conway, H., Bernard, J., Ramos, R., Zahran, S., Perez, D. L., Swar-Eldahab, M., Piganelli, J., Evans-Molina, C., & Felton, J. L. (2026). Altered B cell metabolic pathways characterize type 1 diabetes progression. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkaf330

Vancouver

Conway H, Bernard J, Ramos R, Zahran S, Perez DL, Swar-Eldahab M, et al. Altered B cell metabolic pathways characterize type 1 diabetes progression. The Journal of Immunology. 2026. doi:10.1093/jimmun/vkaf330

BibTeX
@article{Conway2026,
  author = {Conway, Holly and Bernard, Jessica and Ramos, Rachel and Zahran, Sama and Perez, Dianna L and Swar-Eldahab, Mugtaba and Piganelli, Jon and Evans-Molina, Carmella and Felton, Jamie L},
  title = {Altered B cell metabolic pathways characterize type 1 diabetes progression},
  journal = {The Journal of Immunology},
  year = {2026},
  doi = {10.1093/jimmun/vkaf330}
}
Kostenlos starten →